Home Cart Sign in  
Chemical Structure| 51673-84-8 Chemical Structure| 51673-84-8
Chemical Structure| 51673-84-8

*Storage: Sealed in dry,2-8°C.

2,2-Dimethoxyacetaldehyde

CAS No.: 51673-84-8

4.5 *For Research Use Only !

Cat. No.: A208718 Purity: 60 wt. % in H2O

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
5g łÇǶÊÊ In Stock In Stock Login
10g łÇͶÊÊ In Stock In Stock Login
25g łËͶÊÊ In Stock In Stock Login
100g łòî¶ÊÊ In Stock In Stock Login
500g ł§§Í¶ÊÊ Inquiry In Stock Login
1kg łÿòî¶ÊÊ Inquiry In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 5g

    łÇǶÊÊ

  • 10g

    łÇͶÊÊ

  • 25g

    łËͶÊÊ

  • 100g

    łòî¶ÊÊ

  • 500g

    ł§§Í¶ÊÊ

  • 1kg

    łÿòî¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 51673-84-8 ]

CAS No. :51673-84-8
Formula : C4H8O3
Linear Structure Formula :CHOCH(OCH3)2
M.W : 104.10
SMILES Code : COC(OC)C=O
MDL No. :MFCD00134410
InChI Key :OGFKTAMJLKHRAZ-UHFFFAOYSA-N
Pubchem ID :162650

Safety of [ 51673-84-8 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 51673-84-8 ] Show Less

Physicochemical Properties

Num. heavy atoms 7
Num. arom. heavy atoms 0
Fraction Csp3 0.75
Num. rotatable bonds 3
Num. H-bond acceptors 3.0
Num. H-bond donors 0.0
Molar Refractivity 23.71
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

35.53 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.32
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.41
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-0.2
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.8
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.04
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.02

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.03
Solubility 97.3 mg/ml ; 0.935 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

0.13
Solubility 140.0 mg/ml ; 1.34 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.06
Solubility 90.7 mg/ml ; 0.871 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.23 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.48

Application In Synthesis [ 51673-84-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 51673-84-8 ]

[ 51673-84-8 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 51673-84-8 ]
  • [ 17429-02-6 ]
  • [ 18441-43-5 ]
YieldReaction ConditionsOperation in experiment
71% General procedure: To a solution of compound 8 (150 mg, 1.17 mmol) in dry CH2Cl2 (10 ml) at -35 C were added a solution of TiCl4 (0.19 ml, 1.75 mmol) and tributylamine (0.83 ml, 3.5 mmol) in CH2Cl2 (2 ml each). After stirring the resulting solution for 30 minutes at same temperature, 1 ml solution of 2,2-dimethoxy acetaldehye (5.85 mmol) in CH2Cl2 (extracted from 60% aqueous solution) was added and the reaction mixture was allowed to attain room temperature. Once the reaction was complete (confirmed by TLC), water (15 ml) was added to quench the reaction. Workup was done with CH2Cl2 (3 x 15 ml) and after washing the organic portion with brine (25 ml), it was dried over sodium sulphate (2 g). Solvent was removed under reduced pressure and the resulting crude reaction mixture was subjected to column chromatography with ethyl acetate/hexane (3:97). The product was obtained as a colorless liquid in 67% yield (104 mg).
  • 2
  • [ 21109-25-1 ]
  • [ 51673-84-8 ]
  • [ 59795-89-0 ]
  • [ 65-85-0 ]
  • C29H31N3O4 [ No CAS ]
  • 3
  • [ 21109-25-1 ]
  • [ 931-53-3 ]
  • [ 51673-84-8 ]
  • [ 65-85-0 ]
  • C27H33N3O4 [ No CAS ]
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 51673-84-8 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 6342-56-9

A230757 [6342-56-9]

1,1-Dimethoxypropan-2-one

Similarity: 0.77

Chemical Structure| 89-91-8

A536324 [89-91-8]

Methyl 2,2-dimethoxyacetate

Similarity: 0.71

Chemical Structure| 24332-20-5

A522724 [24332-20-5]

1,1,2-Trimethoxyethane

Similarity: 0.63

Chemical Structure| 18370-95-1

A156359 [18370-95-1]

Methyl 2,2,2-trimethoxyacetate

Similarity: 0.63

Chemical Structure| 6065-82-3

A227247 [6065-82-3]

Ethyl diethoxyacetate

Similarity: 0.63

Ethers

Chemical Structure| 6342-56-9

A230757 [6342-56-9]

1,1-Dimethoxypropan-2-one

Similarity: 0.77

Chemical Structure| 89-91-8

A536324 [89-91-8]

Methyl 2,2-dimethoxyacetate

Similarity: 0.71

Chemical Structure| 24332-20-5

A522724 [24332-20-5]

1,1,2-Trimethoxyethane

Similarity: 0.63

Chemical Structure| 18370-95-1

A156359 [18370-95-1]

Methyl 2,2,2-trimethoxyacetate

Similarity: 0.63

Chemical Structure| 6065-82-3

A227247 [6065-82-3]

Ethyl diethoxyacetate

Similarity: 0.63